- Home
- CADL vs HLXB Comparison
CADL vs HLXB Comparison
Compare CADL & HLXB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CADL
- HLXB
- Stock Information
- Founded
- CADL 1999
- HLXB 2021
- Country
- CADL United States
- HLXB United States
- Employees
- CADL N/A
- HLXB N/A
- Industry
- CADL Biotechnology: Pharmaceutical Preparations
- HLXB
- Sector
- CADL Health Care
- HLXB
- Exchange
- CADL Nasdaq
- HLXB NYSE
- Market Cap
- CADL 306.4M
- HLXB 253.2M
- IPO Year
- CADL 2021
- HLXB 2024
- Fundamental
- Price
- CADL $8.09
- HLXB $10.70
- Analyst Decision
- CADL Strong Buy
- HLXB
- Analyst Count
- CADL 4
- HLXB 0
- Target Price
- CADL $21.00
- HLXB N/A
- AVG Volume (30 Days)
- CADL 918.0K
- HLXB 111.1K
- Earning Date
- CADL 03-13-2025
- HLXB 01-01-0001
- Dividend Yield
- CADL N/A
- HLXB N/A
- EPS Growth
- CADL N/A
- HLXB N/A
- EPS
- CADL N/A
- HLXB 0.36
- Revenue
- CADL N/A
- HLXB N/A
- Revenue This Year
- CADL N/A
- HLXB N/A
- Revenue Next Year
- CADL N/A
- HLXB N/A
- P/E Ratio
- CADL N/A
- HLXB $30.10
- Revenue Growth
- CADL N/A
- HLXB N/A
- 52 Week Low
- CADL $1.45
- HLXB $10.14
- 52 Week High
- CADL $14.60
- HLXB $11.59
- Technical
- Relative Strength Index (RSI)
- CADL 49.50
- HLXB N/A
- Support Level
- CADL $7.85
- HLXB N/A
- Resistance Level
- CADL $8.69
- HLXB N/A
- Average True Range (ATR)
- CADL 0.54
- HLXB 0.00
- MACD
- CADL -0.02
- HLXB 0.00
- Stochastic Oscillator
- CADL 54.55
- HLXB 0.00
About CADL Candel Therapeutics Inc.
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.
About HLXB HELIX ACQUISITION CORP. II
Helix Acquisition Corp II is a Blank check company.